Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease.
Fiche publication
Date publication
juillet 2011
Journal
Gut
Auteurs
Membres identifiés du Cancéropôle Est :
Dr OUSSALAH Abderrahim, Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Peyrin-Biroulet L, Oussalah A, Williet N, Pillot C, Bresler L, Bigard MA
Lien Pubmed
Résumé
The aim of the study was to assess whether azathioprine and antitumour necrosis factor (TNF) treatment decrease the long-term need for surgery in patients with Crohn's disease.
Mots clés
Adolescent, Adult, Azathioprine, administration & dosage, Combined Modality Therapy, methods, Crohn Disease, drug therapy, Drug Administration Schedule, Epidemiologic Methods, Female, Humans, Immunosuppressive Agents, administration & dosage, Male, Middle Aged, Prognosis, Time Factors, Tumor Necrosis Factor-alpha, antagonists & inhibitors, Young Adult
Référence
Gut. 2011 Jul;60(7):930-6